Per buyins.net, RPC removed from naked short list.
RADIENT PHARMACEUTICALS CORP (AMEX:RPC) - Radient Pharmaceuticals Corporation, a pharmaceutical company, engages in the research, development, manufacture, and marketing of diagnostic and skin care products. It offers ONKO-SURE, a proprietary in-vitro diagnostic cancer test, which is used for the detection and/or monitoring of lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, and pancreatic cancers. The company also has interests in the Combined Immunogene Therapy, a cancer vaccine therapy technology, which is used to build the bodys immune system and destroy cancer cells. In addition, it provides Elleuxe brand of anti-aging skin care products, including hydrating firming cream, renergie hydrating cleanser, intense hydrating cleanser, visable renewing hydrating softener, and smoothing renewing eye moisturizer. The company sells its products through distributors to hospitals, clinical laboratories, clinics, and other health care organizations primarily in the United States, Canada, Chile, Europe, India, Korea, Taiwan, and Vietnam. It has a collaborative agreement with the Mayo Clinic. The company was formerly known as AMDL, Inc. and changed its name to Radient Pharmaceuticals Corporation in September 2009 to reflect its new corporate direction and branding statements. Radient Pharmaceuticals Corporation was founded in 1988 and is headquartered in Tustin, California.There is a failure to deliver in shares of RPC
naked short list.
